BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38467081)

  • 1. Survey of European Blood and Marrow Transplant (EBMT) nurses to explore the current topical skin management of chronic cutaneous graft versus host disease in the real-world clinical environment.
    Murray J; Liptrott S; Canesi M; Mooyaart J; Kisch A; Piepenbroek B; Stringer J
    Eur J Oncol Nurs; 2024 Apr; 69():102547. PubMed ID: 38467081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
    Spałek A; Grygoruk-Wiśniowska I; Gruenpeter K; Panz-Klapuch M; Helbig G
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
    Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
    Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease.
    Richet C; Huynh A; Dimeglio C; Borel C; Lepage B; Boulinguez S; Marguery MC; Paul C; Bulai Livideanu C
    Dermatology; 2018; 234(1-2):23-30. PubMed ID: 29788024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review.
    Villarreal CD; Alanis JC; Pérez JC; Candiani JO
    An Bras Dermatol; 2016; 91(3):336-43. PubMed ID: 27438202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
    Weitz M; Strahm B; Meerpohl JJ; Bassler D
    Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-
    Bos S; Murray J; Marchetti M; Cheng GS; Bergeron A; Wolff D; Sander C; Sharma A; Badawy SM; Peric Z; Piekarska A; Pidala J; Raj K; Penack O; Kulkarni S; Beestrum M; Linke A; Rutter M; Coleman C; Tonia T; Schoemans H; Stolz D; Vos R
    Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38485149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.
    Buder K; Zirngibl M; Bapistella S; Meerpohl JJ; Strahm B; Bassler D; Weitz M
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009898. PubMed ID: 35679154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
    Olson KA; West K; McCarthy PL
    Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Chronic Graft Versus Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation in Children: A Retrospective Study.
    Shreberk-Hassidim R; Neumark M; Greenberger S; Goldstein G; Hassidim A; Dukler Y; Maly A; Stepensky P; Molho-Pessach V
    Acta Derm Venereol; 2018 Feb; 98(2):206-211. PubMed ID: 29057425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis for the treatment of chronic graft versus host disease.
    Kansu E; Ward D; Sanchez AP; Cunard R; Hayran M; Huseyin B; Vaughan M; Ku G; Curtin P; Mulroney C; Costello C; Castro JE; Wieduwilt M; Corringham S; Ihasz-Davis A; Nelson C; Ball ED
    Hematology; 2022 Dec; 27(1):785-794. PubMed ID: 35802815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations.
    Baumrin E; Loren AW; Falk SJ; Mays JW; Cowen EW
    J Am Acad Dermatol; 2024 Jan; 90(1):1-16. PubMed ID: 36572065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
    Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
    J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation].
    Bykova TA; Kozlov AV; Stancheva NV; Semënova EV; Kulagina II; Bondarenko SN; Vavilov VN; Morozova EV; Zubarovskaia LS; Afanas'ev BV
    Ter Arkh; 2013; 85(8):60-8. PubMed ID: 24137966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease.
    Hillen U; Häusermann P; Massi D; Janin A; Wolff D; Lawitschka A; Greinix H; Meyer R; Ziemer M
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):948-54. PubMed ID: 25265987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical therapy and skin care for transplant-associated atopic dermatitis in children and adolescents.
    Horino S; Yamaguchi Y; Miyabayashi H; Aki H; Nanjo Y; Onuma M; Rikiishi T; Yabe H; Imaizumi M; Sato A; Miura K
    Pediatr Transplant; 2024 Feb; 28(1):e14653. PubMed ID: 37990976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of the type of hematopoietic stem-cell transplant on quality of life and psychopathology].
    Janicsák H; Masszi T; Reményi P; Ungvari GS; Gazdag G
    Ideggyogy Sz; 2023 Jan; 76(1-2):25-35. PubMed ID: 36892298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic management.
    Baumrin E; Loren AW; Falk SJ; Mays JW; Cowen EW
    J Am Acad Dermatol; 2024 Jan; 90(1):19-36. PubMed ID: 36572064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phototherapy and topical treatments for cutaneous graft vs. host disease in haematopoietic stem cell transplantation patients: a scoping review.
    Rostagno E; Campanati A; Mordini N; Cannici C; Cioce M; De Cecco V; Samarani E; Foà R; Olivieri A; Botti S
    J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):1003-1015. PubMed ID: 35279894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers.
    Wolff D; Ayuk F; Elmaagacli A; Bertz H; Lawitschka A; Schleuning M; Meyer RG; Gerbitz A; Hilgendorf I; Hildebrandt GC; Edinger M; Klein S; Halter J; Mousset S; Holler E; Greinix HT
    Biol Blood Marrow Transplant; 2013 May; 19(5):767-76. PubMed ID: 23376495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.